Clinical Trial Update: Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial update evaluating Endometrial Regenerative Cells for critical limb ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Vascular Disease

Drugs mentioned

• Endometrial Regenerative Cells

Snippet

Sponsor: Medistem Inc. | Conditions: Peripheral Vascular Diseases | Phase 1, Phase 2 | Status: UNKNOWN